Date:03-May-2024  Time: 10:34 AM
 
 
        
Sandu Pharmaceuticals Ltd
Quarters:       (Rs. In Crores)
ParticularsDec 2023Sep 2023Jun 2023Mar 2023
Type3Qtr2Qtr1Qtr4Qtr
Net Sales17.4316.6117.6615.26
Other Income0.030.090.000.04
Total Income17.4616.6917.6615.31
Total Expenditure 16.9215.7817.3014.78
Operating Profit0.540.910.360.53
Interest0.020.010.020.02
Gross Profit0.520.900.330.51
Depreciation0.140.130.120.13
Tax0.110.210.060.10
Deferred Tax0.060.000.040.00
Reported Profit After Tax0.210.550.110.27
Source:Capital Market
 
Useful linksNSEIBSEI SEBIINSDLI NCDEXI CDSLIRBI      Careers | Feedback | Sitemap | Disclaimer | Privacy Policy | Grievances
Sebi Reg No: NSE INB231168734(CM) INF231168734(F&O) Sebi Reg No: BSE INB011168730 INF011168730   NCDEX: Membership Code: 00774
MCX: Membership Code: 31560  Mutual Funds: ARN0843.
FMC Unique Membership Code: MCX/TCM/CORP/1106
2006-07 © Senator Securities Pvt. Ltd. All rights reserved
FMC Unique Membership Code: NCDEX/TCM/CORP/0760
Design, developed & maintained by C-MOTS Infotech(ISO 9001:2000 certified)
Content powered by capitalmarket.com